{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T21:00:37Z","timestamp":1777323637826,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,27]]},"DOI":"10.7759\/cureus.107831","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T20:27:26Z","timestamp":1777321646000},"source":"Crossref","is-referenced-by-count":0,"title":["Thyroid Eye Disease, Glycemic Control, and the Role of a One-Stop Clinic Approach: A Retrospective Audit Study"],"prefix":"10.7759","author":[{"given":"Keiko","family":"Carter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bashir","family":"Mahamud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Furhana","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Godwin","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gideon","family":"Mlawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v6.i8.1073","article-title":"Steroid hyperglycemia: prevalence, early detection and therapeutic recommendations: a narrative review","volume":"6","author":"Tamez-P\u00e9rez HE","year":"2015","unstructured":"Tamez-P\u00e9rez HE, Quintanilla-Flores DL, Rodr\u00edguez-Guti\u00e9rrez R, Gonz\u00e1lez-Gonz\u00e1lez JG, Tamez-Pe\u00f1a AL. Steroid hyperglycemia: prevalence, early detection and therapeutic recommendations: a narrative review. World J Diabetes. 2015, 6:1073-81. 10.4239\/wjd.v6.i8.1073","journal-title":"World J Diabetes"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-019-0664-z","article-title":"A survey of current practices by the British Oculoplastic Surgery Society (BOPSS) and recommendations for delivering a sustainable multidisciplinary approach to thyroid eye disease in the United Kingdom","volume":"34","author":"Lee V","year":"2020","unstructured":"Lee V, Avari P, Williams B, Perros P, Dayan C. A survey of current practices by the British Oculoplastic Surgery Society (BOPSS) and recommendations for delivering a sustainable multidisciplinary approach to thyroid eye disease in the United Kingdom. Eye (Lond). 2020, 34:1662-71. 10.1038\/s41433-019-0664-z","journal-title":"Eye (Lond)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-023-01393-6","article-title":"Practical guide to glucocorticoid induced hyperglycaemia and diabetes","volume":"14","author":"Barker HL","year":"2023","unstructured":"Barker HL, Morrison D, Llano A, Sainsbury CA, Jones GC. Practical guide to glucocorticoid induced hyperglycaemia and diabetes. Diabetes Ther. 2023, 14:937-45. 10.1007\/s13300-023-01393-6","journal-title":"Diabetes Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13675","article-title":"Management of hyperglycaemia and steroid (glucocorticoid) therapy: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group","volume":"35","author":"Roberts A","year":"2018","unstructured":"Roberts A, James J, Dhatariya K. Management of hyperglycaemia and steroid (glucocorticoid) therapy: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group. Diabet Med. 2018, 35:1011-7. 10.1111\/dme.13675","journal-title":"Diabet Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy","volume":"185","author":"Bartalena L","year":"2021","unstructured":"Bartalena L, Kahaly GJ, Baldeschi L, et al.. The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy. Eur J Endocrinol. 2021, 185:G43-67. 10.1530\/EJE-21-0479","journal-title":"Eur J Endocrinol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2024.0633","article-title":"Ablative versus conservative approach for hyperthyroidism treatment in patients with Graves\u2019 orbitopathy: a retrospective cohort study","volume":"35","author":"Cosentino G","year":"2025","unstructured":"Cosentino G, Lanzolla G, Comi S, et al.. Ablative versus conservative approach for hyperthyroidism treatment in patients with Graves\u2019 orbitopathy: a retrospective cohort study. Thyroid. 2025, 35:298-306. 10.1089\/thy.2024.0633","journal-title":"Thyroid"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2011.03.001","article-title":"Graves' disease: diagnostic and therapeutic challenges (multimedia activity)","volume":"124","author":"Kahaly GJ","year":"2011","unstructured":"Kahaly GJ, Grebe SK, Lupo MA, McDonald N, Sipos JA. Graves' disease: diagnostic and therapeutic challenges (multimedia activity). Am J Med. 2011, 124:S2-3. 10.1016\/j.amjmed.2011.03.001","journal-title":"Am J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1089\/105072502761016476","article-title":"Epidemiology and prevention of Graves' ophthalmopathy","volume":"12","author":"Wiersinga WM","year":"2002","unstructured":"Wiersinga WM, Bartalena L. Epidemiology and prevention of Graves' ophthalmopathy. Thyroid. 2002, 12:855-60. 10.1089\/105072502761016476","journal-title":"Thyroid"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2017.0365","article-title":"Death by suicide in Graves\u2019 disease and Graves\u2019 orbitopathy: a nationwide Danish register study","volume":"27","author":"Ferl\u00f8v-Schwensen C","year":"2017","unstructured":"Ferl\u00f8v-Schwensen C, Brix TH, Heged\u00fcs L. Death by suicide in Graves\u2019 disease and Graves\u2019 orbitopathy: a nationwide Danish register study. Thyroid. 2017, 27:1475-80. 10.1089\/thy.2017.0365","journal-title":"Thyroid"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2022.1002","article-title":"Nationwide incidence of thyroid eye disease and cumulative incidence of strabismus and surgical interventions in Denmark","volume":"140","author":"Boulakh L","year":"2022","unstructured":"Boulakh L, Nygaard B, Bek T, et al.. Nationwide incidence of thyroid eye disease and cumulative incidence of strabismus and surgical interventions in Denmark. JAMA Ophthalmol. 2022, 140:667-73. 10.1001\/jamaophthalmol.2022.1002","journal-title":"JAMA Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.669871","article-title":"A \u2018real life\u2019 service evaluation model for multidisciplinary thyroid eye services","volume":"12","author":"Farag S","year":"2021","unstructured":"Farag S, Feeney C, Lee V, et al.. A \u2018real life\u2019 service evaluation model for multidisciplinary thyroid eye services. Front Endocrinol (Lausanne). 2021, 12:669871. 10.3389\/fendo.2021.669871","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1251209","article-title":"HbA1c: an independent risk factor for dysthyroid optic neuropathy","volume":"14","author":"Wang X","year":"2023","unstructured":"Wang X, Ye H, Chen R, Yang S, Zhang T, Xiao W, Yang H. HbA1c: an independent risk factor for dysthyroid optic neuropathy. Front Endocrinol (Lausanne). 2023, 14:1251209. 10.3389\/fendo.2023.1251209","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10102154","article-title":"A practical guide for the management of steroid induced hyperglycaemia in the hospital","volume":"10","author":"Aberer F","year":"2021","unstructured":"Aberer F, Hochfellner DA, Sourij H, Mader JK. A practical guide for the management of steroid induced hyperglycaemia in the hospital. J Clin Med. 2021, 10:10.3390\/jcm10102154","journal-title":"J Clin Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2024.0629","article-title":"Factors associated with response to intravenous glucocorticoids in active moderate-to-severe thyroid eye disease","volume":"35","author":"Baczewska N","year":"2025","unstructured":"Baczewska N, Alexopoulou O, Constantinescu SM, Daumerie C, Coutel M, Boschi A, Burlacu MC. Factors associated with response to intravenous glucocorticoids in active moderate-to-severe thyroid eye disease. Thyroid. 2025, 35:424-32. 10.1089\/thy.2024.0629","journal-title":"Thyroid"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(25)00066-X","article-title":"Thyroid eye disease (Graves' orbitopathy): clinical presentation, epidemiology, pathogenesis, and management","volume":"13","author":"Wiersinga WM","year":"2025","unstructured":"Wiersinga WM, Eckstein AK, \u017darkovi\u0107 M. Thyroid eye disease (Graves' orbitopathy): clinical presentation, epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinol. 2025, 13:600-14. 10.1016\/S2213-8587(25)00066-X","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2020.35.e177","article-title":"Intravenous glucocorticoid treatment for Korean Graves\u2019 ophthalmopathy patients","volume":"35","author":"Ahn HY","year":"2020","unstructured":"Ahn HY, Lee JK. Intravenous glucocorticoid treatment for Korean Graves\u2019 ophthalmopathy patients. J Korean Med Sci. 2020, 35:e177. 10.3346\/jkms.2020.35.e177","journal-title":"J Korean Med Sci"},{"key":"ref17","article-title":"Prevalence of diabetes following intravenous methylprednisolone therapy for Graves\u2019 ophthalmopathy","volume":"15","author":"Mettayil J","year":"2008","unstructured":"Mettayil J, Matthews L, Neoh C, Dickinson A, Perros P, Pearce S. Prevalence of diabetes following intravenous methylprednisolone therapy for Graves\u2019 ophthalmopathy. Endocr Abstr. 2008, 15:339.","journal-title":"Endocr Abstr"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.01.043","article-title":"Risk of corticosteroid-induced hyperglycemia requiring medical therapy among patients with inflammatory eye diseases","volume":"119","author":"Udoetuk JD","year":"2012","unstructured":"Udoetuk JD, Dai Y, Ying GS, et al.. Risk of corticosteroid-induced hyperglycemia requiring medical therapy among patients with inflammatory eye diseases. Ophthalmology. 2012, 119:1569-74. 10.1016\/j.ophtha.2012.01.043","journal-title":"Ophthalmology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(03)00818-2","article-title":"Intravenous pulse methylprednisolone therapy in eye disease: effect on glucose tolerance","volume":"110","author":"Feldman-Billard S","year":"2003","unstructured":"Feldman-Billard S, Lissak B, Benrabah R, Kassaei R, H\u00e9ron E. Intravenous pulse methylprednisolone therapy in eye disease: effect on glucose tolerance. Ophthalmology. 2003, 110:2369-71. 10.1016\/S0161-6420(03)00818-2","journal-title":"Ophthalmology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/484330-thyroid-eye-disease-glycemic-control-and-the-role-of-a-one-stop-clinic-approach-a-retrospective-audit-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T20:27:27Z","timestamp":1777321647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/484330-thyroid-eye-disease-glycemic-control-and-the-role-of-a-one-stop-clinic-approach-a-retrospective-audit-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.107831","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,27]]}}}